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Purpose:  Cardiac  perforations  due  to  pacing  and  implantable  deﬁbrillator  lead  displacement
are rare  and  their  detection  may  be  difﬁcult.  The  goal  of  this  study  was  to  review  the  clinical
and imaging  presentation  of  cardiac  perforation  related  to  pacing  lead  displacement.
Patients  and  methods:  The  clinical  and  imaging  ﬁles  of  four  patients  (two  men  and  two  women)
who experienced  cardiac  perforation  related  to  pacing  lead  displacement  were  reviewed.  The
four patients  were  investigated  in  our  radiology  department  over  a  24-month-period.
Results: Two  patients  had  clinical  symptoms  at  the  time  lead  displacement  was  detected  and
the other  two  were  free  of  symptoms.  In  all  patients,  lead  displacement  was  visible  on  imaging
examinations  in  retrospect  but  was  not  detected  prospectively.
Conclusion:  Radiologists  should  pay  attention  to  the  position  of  the  tips  of  the  leads  on  chest
X-ray and  CT,  even  late  after  the  implantation  and  in  asymptomatic  patients.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Cardiac  perforations  due  to  pacing  lead  displacement  are  rare,  occurring  in  around  0.1—1%
of  cases  for  pacemakers  and  in  0.6—5.2%  of  cases  for  deﬁbrillators  [1].  They  are  particularly
rare  when  they  occur  late  after  implantation  of  the  device  (more  than  30  days  after  the
procedure).  The  diagnosis  is  generally  made  upon  the  six  monthly  check  on  the  device  and
the  displacement  can  be  conﬁrmed  by  imaging,  which  provides  information  about  the  site
of  the  displaced  lead.  In  other  circumstances,  and  particularly  in  emergency  situations,
imaging  is  performed  before  the  cardiology  assessment  and  it  is  up  to  the  radiologist  to
suggest  the  diagnosis.
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hundred  and  ﬁfty  mL  of  serous-bloody  pericardial  ﬂuid  were34  
The  goal  of  this  study  was  to  review  the  clinical  and  imag-
ng  presentation  of  cardiac  perforation  related  to  pacing
ead  displacement.
atients and methods
e  retrospectively  reviewed  all  the  cases  of  cardiac  per-
oration  related  to  pacing  lead  displacement  tagged  in  our
icture  Archiving  and  Communication  System  (Carestream
ue  version  11.4.0.1253;  Carestream  Health,  Inc.,  Toronto,
anada)  and  matching  the  key  words  ‘‘perforation’’  and/or
‘heart’’  and/or  ‘‘cardiac’’  and/or  ‘‘lead’’  over  a  24-
onth-period  (between  August  2011  and  September  2013
nclusively).




 24-year-old  woman  presented  to  the  emergency  depart-
ent  with  respiration-dependent  left  basal  chest  pain,
hich  had  developed  three  days  previously  and  was  asso-
iated  with  breathlessness.  She  had  neither  cough  nor
ever.  Her  past  history  included  catecholaminergic  tachy-
ardia  for  which  a  single  chamber  automatic  deﬁbrillator
ad  been  implanted  three  years  previously.  The  deﬁbril-
ation  lead  had  been  replaced  six  weeks  prior  to  her
resentation  (active  ﬁxation  lead)  because  of  malfunc-
ion  and  the  post-implantation  cardiology  review  found  no
bnormality.  Based  on  her  clinical  presentation,  the  recent
istory  of  the  procedure  and  raised  D-dimers  (1239  ng/mL
normal  value  <  500  ng/mL]  with  a  CRP  of  7  mg/L  [normal
alue  <  10  mg/L]),  an  inspiration  and  expiration  X-ray  was
erformed  followed  by  a  chest  CT  angiogram.
The  chest  X-ray  showed  no  gaseous  pleural  detachment.
n  retrospect,  the  pacing  lead  was  found  to  have  been
isplaced  compared  to  the  post-procedure  investigation  per-
ormed  six  weeks  previously  and  she  had  a  small  left  pleural
ffusion  (Fig.  1).
CT  angiogram  showed  no  enhancement  defect  in  the  pul-
onary  arteries  although  in  retrospection  the  end  of  the
acing  lead  was  found  to  have  perforated  the  myocardium
nd  pericardium,  passing  28  mm  outside  of  the  myocardium
nd  coming  into  contact  with  the  anterior  arch  of  the  5th
eft  rib.  She  had  a  moderate  left  sided  pleural  effusion  but
o  pericardial  effusion.  After  returning  home  following  her
onsultation  at  the  emergency  department  the  patient  was
ecalled  after  the  CT  angiogram  had  been  reread.  Patient
ondition  ultimately  improved  after  extracting  the  displaced
ead  and  inserting  a  new  one.
Also  in  retrospect,  the  tip  of  the  lead  already  appeared
o  be  incorrectly  positioned  on  the  post-implantation  lateral
lm,  projecting  unusually  forwards.
atient 2 33-year-old  man  presented  to  cardiology  for  routine  follow
p  of  a  dual  chamber  pacemaker  with  active  ﬁxation  leads
a
s
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mplanted  nine  months  previously  for  paroxysmal  complete
trioventricular  block  (Fig.  2).  The  patient  was  free  of  any
ymptoms.  When  the  device  was  checked  the  cardiologist
ound  defective  capture  and  sensing  in  the  right  atrial  lead,
hich  was  reprogrammed.  He  was  then  offered  a  further
ollow  up  evaluation  at  six  months.  Later  during  the  day,
he  radiologist  interpreted  the  chest  X-ray  and  found  that
he  right  atrial  lead  was  abnormally  positioned.  The  patient
as  recalled  for  a chest  CT  with  cardiac  synchronization,
hich  conﬁrmed  that  the  tip  of  the  lead  had  perforated  and
ntered  over  2  cm  into  the  middle  lobe  of  the  lung.  He  had
either  pericardial  nor  pleural  effusion,  nor  ground  glass  nor
onsolidation  in  the  lung  parenchyma.  The  patient  had  a
avorable  outcome  after  the  displaced  lead  was  removed.
atient 3
 62-year-old  man  who  had  had  a  focal  atrial  tachycardia
blated  from  his  left  atrium  four  years  previously  was  admit-
ed  to  the  emergency  department  in  another  hospital  with
alpitations.  His  electrocardiogram  (ECG)  showed  a  re-entry
achycardia  of  over  200  beats/minute,  which  was  treated
ith  verapamil.  Shortly  afterwards,  the  patient  developed
 very  slow  bradycardia  with  long  pauses  which  required  a
emporary  external  pacemaker  to  be  inserted  and  he  was
hen  transferred  to  our  hospital  for  radiofrequency  abla-
ion  of  the  cardiac  arrhythmia.  His  pre-procedure  cardiac  CT
ngiogram  showed  perforation  of  the  apex  of  the  right  ven-
ricle  with  displacement  of  the  lead  more  than  6  cm  outside
f  the  myocardium,  the  tip  of  the  lead  coming  into  contact
ith  the  diaphragm  (Fig.  3).  This  perforation  could  not  have
een  suspected  from  the  chest  X-ray,  which  was  performed
t  the  patient’s  bedside.  The  patient  improved  after  removal
f  the  temporary  lead  and  radiofrequency  ablation.
atient 4
 69-year-old  woman  was  referred  to  the  emergency  depart-
ent  by  her  general  practitioner  because  of  worsening
f  clinical  condition,  abdominal  pain  and  grade  IV  dys-
nea.  The  patient  had  past  history  including  atrial  disease
alternating  sinus  pauses  and  episodes  of  tachyarrhyth-
ia  on  a  Holter  ECG)  for  which  a pacemaker  had  been
mplanted  three  months  previously  (Fig.  4).  An  outpatient
lood  sample  showed  a  severe  acute  phase  reaction  with
cute  renal  failure,  hepatitic  changes  and  vitamin  K  antag-
nist  (VKA)  overdosage,  with  an  INR  >  7.  As  a result  of  her
linical  presentation,  an  acute  abdominal  condition  with
econdary  dyspnea  was  ﬁrst  considered  and  an  unenhanced
bdominal  CT  (not  enhanced  because  of  her  renal  failure)
hich  was  performed  before  the  chest  X-ray  showed  ﬁrstly
cute  cholecystitis  and  secondly  a  large  hemopericardium.
bdominal  ultrasonography  conﬁrmed  acute  cholecystitis
nd  also  showed  signs  of  a  cardiac  liver.  The  patient  was
hen  directly  transferred  to  the  cardiology  intensive  care
nit  where  an  echocardiogram  conﬁrmed  a  large  pericardial
ffusion  with  severe  impact  on  the  cardiac  cavities.  Ninespirated  followed  by  improvement  in  cardiorespiratory
tatus.  One  week  later,  cardiac  CT  angiogram  conﬁrmed  dis-
lacement  of  the  lead,  the  tip  of  which  had  penetrated  the
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Figure 1. Thirty-four-year-old female patient complaining of left basal chest pain. a: postero-anterior chest X-ray the day after replacing
the deﬁbrillator lead. No complications are seen and the lead appears to be correctly positioned (arrowhead); b: lateral chest X-ray
performed on the same day. In retrospect the tip of the lead appears to lie too anteriorly (arrowhead). Note the projection of the arm
over the cardio-mediastinal shadow; c and d: postero-anterior (in inspiration) and lateral chest X-ray six weeks later in the emergency
department. Displacement of the pacing lead can be seen compared to the previous investigation on both views with a more tortuous
appearance of the tip of the lead on the lateral ﬁlm. The exact site of the end of the lead cannot however be identiﬁed (arrows). This is

















dby the pacing lead, the end of which has come into contact with 
pleural effusion (white star); f: multiplanar reconstruction along th
myocardium (arrow).
epicardial  fat  by  more  than  8  mm  with  complete  resolution
of  the  pericardial  effusion.  In  retrospect,  the  lead  already
appeared  incorrectly  positioned  on  the  post-implantation
investigation  performed  three  months  previously,  projecting
unusually  low  beneath  the  left  hemi  diaphragm.  Following
this  episode  the  patient’s  VKA  was  stopped  and  replaced
with  aspirin.  The  displaced  lead  was  not  removed  because  of
the  patient’s  co-morbidities  and  she  improved,  with  a  satis-
factory  pacemaker  check  two  years  after  the  acute  episode.
The  cholecystitis  was  treated  medically  and  also  improved.
Discussion
These  four  cases  highlight  the  difﬁculties  these  perfora-
tions  raise  both  for  the  clinician  (the  relatively  non-speciﬁc
clinical  features  or  even  asymptomatic  nature  of  the  per-
foration,  possibly  developing  late  after  implantation  of  the
device)  and  the  radiologist  (comparison  with  previous  inves-
tigations  is  not  performed  routinely,  limited  attention  paid





pnterior arch of the 5th left rib (arrow). Note the associated left
 of the pacing lead showing its displacement 28 mm outside of the
It  is  estimated  that  over  60,000  and  14,000  pacemakers
nd  cardiac  deﬁbrillators  are  implanted  annually  in  France
2,3].  The  corresponding  ﬁgures  in  Belgium  are  around
0,000  pacemakers  and  2000  deﬁbrillators  [4,5].
Cardiac  pacemaker  lead  complications  occur  in  3.9  to
.6%  of  implantations  depending  on  the  series  [1]. Perfora-
ions  by  leads  are  rare,  developing  in  the  region  of  0.1—1%
f  cases  for  pacemakers  and  0.6—5.2%  for  deﬁbrillators  [1].
erforation  is  described  as  acute,  subacute,  or  chronic  (late)
epending  on  the  time  to  onset  of  symptoms:  acute  when
hey  occur  within  24  hours  and  chronic  when  they  occur  more
han  30  days  after  implantation  [6]. Subacute  and  chronic
erforations  are  rarer  and  often  missed  [1].
Clinical  ﬁndings  include  chest  pain,  dyspnea,  hypotension
r  syncope.  They  are  relatively  non-speciﬁc  and  depend  on
he  site  of  the  displaced  lead  (pericardium,  pleural  space,
ung  parenchyma  or  chest  wall):  The  clinical  course  may  be
ramatic  if  tamponade  or  massive  hemothorax  occurs  and
ay  ultimately  be  fatal.  Inappropriate  electrical  stimula-
ion  of  the  chest  wall  muscle  or  diaphragm  may  also  occur
nd  occasional  cases  of  perforation  have  been  described
resenting  with  hiccups  [7].  The  perforation  may  also  be
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Figure 2. Asymptomatic 33-year-old man (patient 2): a: postero-anterior chest X-ray post-implantation showing the tip of the atrial
lead projecting from the right atrium (arrowhead); b: investigation performed six months later during a routine follow up consultation
showing displacement of the atrial lead which projects into the right hilum (arrow); c: chest CT angiogram with cardiac synchronization











































In the middle lobe parenchyma (arrow). Note that neither a perica
resent in the parenchyma in contact with the lead.
symptomatic.  Hirschl  et  al.  reviewed  100  chest  CT  exami-
ations  in  asymptomatic  patients  with  implantable  cardiac
evices  and  found  perforation  in  15%  of  cases,  more  com-
only  with  atrial  (15%  of  atrial  leads)  than  ventricular
eads  (6%  of  ventricular  leads)  [8].  Perforations  due  to  right
entricular  leads  occurred  signiﬁcantly  more  often  with
eﬁbrillators  (14%)  than  with  pacemakers  (3%).
The  risk  factors  for  perforation  are  the  use  of  active  ﬁx-
tion  leads,  concomitant  transvenous  pacing,  corticosteroid
herapy,  anticoagulation,  female  sex  and  a  body  mass  index
f  under  20  kg/m2 [1].
A cardiology  review  of  the  device  (interrogating  the
nstrument  using  a  timer  with  telemetry)  may  ﬁnd  abnor-
alities,  which  have  developed  compared  to  the  previous
heck,  suggesting  displacement  of  the  lead.  Normal
arameters,  however,  do  not  exclude  perforation  [8].
chocardiography  may  show  the  tip  of  the  displaced  lead
nd  a  pericardial  effusion  when  this  is  present  but  may  also
e  non-contributory  [9].
The  diagnosis  is  made  more  from  imaging  than  from  clini-
al  features  or  a  cardiology  assessment.  A  perforation  should
e  suspected  on  a  chest  X-ray  if  the  lead  is  abnormally
ositioned,  generally  more  caudal  than  usual  for  ventricu-
ar  leads  [10].  Films  should  be  examined  for  a  pleural  or
l
T
ror pleural effusion, ground glass appearances or consolidation are
ericardial  effusion,  although  these  may  not  be  present.  The
lassical  lead  positions  are  well  known  and  reported:  the
ip  of  the  right  ventricular  lead  projecting  into  the  apex  of
he  right  ventricle,  the  atrial  lead  projecting  into  the  right
trium  and  speciﬁcally  into  the  right  auricle  and  the  left  ven-
ricular  lead  projecting  along  the  path  of  the  coronary  sinus
nd  one  of  its  branches  [11,12]. To  our  knowledge,  there  are
o  more  speciﬁc  criteria  than  ‘‘unusual’’  lead  site  to  sug-
est  malposition  on  the  chest  X-ray  [10—12].  It is  therefore
ssential  to  compare  the  investigation  with  previous  X-rays
nd  particularly  with  the  post-procedure  view  in  order  to
ook  for  any  change  in  lead  position.
The  site  of  the  displaced  lead  can  be  better  identiﬁed
y  CT,  ideally  carried  out  with  cardiac  synchronization  and
mages  reconstructed  in  diastole  [10].  Myocardial  penetra-
ion  should  be  suspected  if  the  tip  of  the  lead  passes  up  to
 mm  into  the  epicardial  fat  and  if  it  is  located  entirely  in
he  epicardial  fat,  myocardial  perforation  is  very  likely  to  be
resent  [10].  In  the  same  way  as  for  standard  X-rays,  ﬁlms
hould  be  examined  for  a  pleural  or  pericardial  effusion.
nterpretation  is  often  hindered  by  metal  artifacts  from  the
ead  and  requires  an  appropriate  windowing  for  detection.
he  average  attenuation  value  of  electrostimulation  mate-
ials  is  around  3000  HU  [13], but  to  our  knowledge,  no  study
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Figure 3. Asymptomatic 62-year-old male patient (patient 3): a: chest X-ray at the patient’s bedside showing the tip of the temporary
lead projecting into the apex of the heart (arrow); b: incidental ﬁnding of perforation of the apex of the right ventricle in the pre-procedure
cardiac CT angiogram, with displacement of the lead more than 6 cm outside of the heart. The tip of the lead has come into contact with
the diaphragm on MIP reconstructions (arrow); c: 3D reconstructions of the cardiac perforation by the lead.
Figure 4. Sixty-nine-year-old woman with general condition worsening, abdominal pain and dyspnea (patient 4). a: post-procedure,
postero-anterior chest X-ray showing no complications apart from an unusually low projection of the tip of the ventricular lead (arrow); b:
chest X-ray in the emergency department showing enlargement of the cardio-mediastinal shadow with a globular appearance (arrowheads);
c: cardiac CT angiogram performed a week later conﬁrming myocardial perforation by the right ventricular lead, the tip of which has entered






































































as  sought  to  examine  the  optimal  windowing  in  a  chest  CT
n  patients  with  cardiac  pacing  leads.  From  our  own  experi-
nce,  unfortunately,  there  is  no  optimal  window  to  visualize
he  electrostimulation  materials  as  the  artifacts  generated
emain  present  regardless  of  the  center  and  width  of  the
indow.  The  only  advice  we  can  give  to  radiologists  is  to
aintain  the  center  of  the  window  such  that  soft  tissues  can
e  visualized  usually  at  +50  HU  and  that  the  width  of  the  win-
ow  be  increased  in  order  to  reduce  the  blurring  produced
y  metal  artifacts  from  the  leads.  Empirically,  therefore,
 width  of  approximately  1200  HU  has  for  example  enabled
s  to  moderately  reduce  these  artefacts  but  not  to  abol-
sh  them  completely.  It  is  possible  that  the  spectral  CT  may
educe  the  metal  artefacts  and  therefore  improve  detection
f  these  malpositions  or  displacements.  The  use  of  multi-
nergy  should  conﬁrm  its  exact  site  by  limiting  artefacts  at
he  tip  of  the  lead  particularly  when  it  is  located  in  the
eep  epicardial  fat,  a  few  millimeters  from  the  epicardial
urface.  There  are  currently  no  data  in  the  literature  about
hese  speciﬁc  cases  and  a  prospective  study  should  be  under-
aken  to  deﬁne  the  role  of  multi-energy  in  reducing  artifacts
rom  pacing  materials  [14].
There  is  no  consensus  on  the  management  of  displaced
eads  and  the  perforations  they  cause,  particularly  when
hey  are  asymptomatic.  However,  explantation  of  the  lead
s  the  ﬁrst  option  [15].  This  has  a  mortality  rate  that  ranges
etween  0.4  and  0.8%,  but  appears  to  carry  a  greater  risk
han  that  of  a  defective  non-infected  lead.  The  alternative
s  to  disconnect  the  old  lead  and  sheathe  it.  This  appears
o  have  a  major  complication  rate  similar  to  that  of  explan-
ation,  but  a  lower  rate  of  minor  complications.  The  main
isadvantage  of  this  approach  is  the  possibility  of  inter-
erence  between  the  old  lead  left  in  place  and  the  new
mplanted  lead.
The  choice  of  procedure  or  decision  not  to  intervene  but
pt  for  regular  monitoring  requires  a  specialist  opinion.  Sus-
ected  perforation  on  CT  in  asymptomatic  patient  is  not
nough  on  its  own  to  justify  removing  the  lead  [8].
Based  on  these  clinical  cases  we  have  reviewed  the
iagnostic  difﬁculties  which  cardiac  perforations  from  lead
isplacement  raise,  particularly  when  they  occur  late  after
mplantation.  As  clinical  ﬁndings  are  relatively  non-speciﬁc
r  even  absent,  radiologists  should  always  examine  the  path
f  leads  in  any  patient  with  an  implanted  cardiac  device.
o  do  this,  it  is  essential  to  compare  the  chest  X-ray  with
revious  X-rays  and  particularly  with  the  ﬁrst  investigation
ost-implantation.  To  our  knowledge,  however,  there  are
o  more  speciﬁc  criteria  than  an  unusual  site  of  the  leads,
hich  suggest  that  they  are  mal-positioned  on  the  chest  X-
ay.  From  our  own  experience  an  unusually  caudal  site  on  the
osterior  anterior  ﬁlm  or  anterior  site  on  the  lateral  ﬁlm  of
he  tip  of  the  right  ventricular  lead  should  suggest  myocar-
ial  perforation  and  warrants  additional  CT  investigation,
hich  should  ideally  be  carried  out  with  cardiac  synchroniza-
ion  and  reconstructions  in  diastole.  The  radiologists  should
ay  attention  to  the  position  of  the  tips  of  the  leads  with
espect  to  the  epicardial  fat  on  CT,  although  unfortunately,
here  is  no  optimal  density  window  to  visualize  pacing  mate-
ials  and  the  artefacts  produced  persist  regardless  of  the
[T.  Kirchgesner  et  al.
indow  chosen.  The  possible  role  of  spectral  CT  in  reduc-
ng  artefacts  from  these  leads  and  how  well  it  performs  in
ocating  leads  precisely,  still  need  to  be  demonstrated  in  the
uture.
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